VVUS - Vivus Inc - SEC Form 4 Insider Trading Screener
26 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
| S | 12 | +1 | +0 | -1 | +0 |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018-11-06 | VVUS | Oki Mark K | CFO, CAO | P - Purchase | $4.07 | +10,000 | 10,000 | New | +$40,700 | ||||||
2018-06-01 | VVUS | Rosenman Herm | Dir | P - Purchase | $0.77 | +50,000 | 336,671 | +17% | +$38,500 | ||||||
2018-05-29 | VVUS | Rosenman Herm | Dir | P - Purchase | $0.79 | +50,000 | 286,671 | +21% | +$39,500 | ||||||
| D | 2018-05-21 | VVUS | Rosenman Herm | Dir | P - Purchase | $0.81 | +100,000 | 236,671 | +73% | +$81,000 | |||||
2018-05-18 | VVUS | Amos John P. | CEO | P - Purchase | $0.77 | +270,000 | 1,708,500 | +19% | +$208,089 | ||||||
2018-05-18 | VVUS | Amos John P. | CEO | S - Sale | $0.77 | -1,500 | 1,708,500 | 0% | -$1,156 | ||||||
2018-05-17 | VVUS | Amos John P. | CEO | P - Purchase | $0.69 | +360,000 | 1,440,000 | +33% | +$249,228 | ||||||
| M | 2018-05-15 | VVUS | Amos John P. | CEO | P - Purchase | $0.56 | +540,000 | 1,080,000 | +100% | +$303,075 | |||||
| M | 2018-05-11 | VVUS | Amos John P. | CEO | P - Purchase | $0.52 | +540,000 | 540,000 | New | +$278,586 | |||||
2018-04-03 | VVUS | Varghese Santosh T | Chief Medical Officer | S - Sale | $0.34 | -390 | 71,415 | -1% | -$132 | ||||||
2018-01-31 | VVUS | Varghese Santosh T | Chief Medical Officer | S - Sale | $0.43 | -491 | 71,805 | -1% | -$211 | ||||||
2018-01-01 | VVUS | Varghese Santosh T | Chief Medical Officer | S - Sale | $0.51 | -444 | 72,296 | -1% | -$226 | ||||||
2017-10-03 | VVUS | Varghese Santosh T | Chief Medical Officer | S - Sale | $0.97 | -434 | 72,740 | -1% | -$421 | ||||||
2017-07-03 | VVUS | Varghese Santosh T | Chief Medical Officer | S - Sale | $1.23 | -423 | 73,174 | -1% | -$520 | ||||||
2017-04-04 | VVUS | Varghese Santosh T | Chief Medical Officer | S - Sale | $1.08 | -440 | 73,597 | -1% | -$475 | +1 | 0 | 0 | |||
| M | 2017-03-08 | VVUS | North Tide Capital, LLC | 10% | S - Sale | $1.16 | -1,149,400 | 10,466,700 | -10% | -$1,331,833 | -2 | -2 | -7 | ||
| M | 2017-03-03 | VVUS | North Tide Capital, LLC | 10% | S - Sale | $1.08 | -192,800 | 11,616,100 | -2% | -$208,744 | -4 | +3 | -2 | ||
| M | 2017-02-28 | VVUS | North Tide Capital, LLC | 10% | S - Sale | $1.13 | -160,100 | 11,808,900 | -1% | -$181,139 | -2 | -6 | -2 | ||
| M | 2017-02-23 | VVUS | North Tide Capital, LLC | 10% | S - Sale | $1.14 | -333,000 | 11,969,000 | -3% | -$380,485 | 0 | -3 | -2 | ||
| M | 2017-02-17 | VVUS | North Tide Capital, LLC | 10% | S - Sale | $1.11 | -161,800 | 12,302,000 | -1% | -$179,525 | +5 | +1 | -5 | ||
| M | 2017-02-14 | VVUS | North Tide Capital, LLC | 10% | S - Sale | $1.10 | -305,090 | 12,463,800 | -2% | -$336,250 | +1 | +8 | +7 | ||
| M | 2017-02-09 | VVUS | North Tide Capital, LLC | 10% | S - Sale | $1.11 | -176,410 | 12,768,890 | -1% | -$195,281 | 0 | -1 | +1 | ||
| M | 2017-02-06 | VVUS | North Tide Capital, LLC | 10% | S - Sale | $1.06 | -563,527 | 12,945,300 | -4% | -$599,545 | +3 | +2 | +12 | ||
| M | 2017-02-01 | VVUS | North Tide Capital, LLC | 10% | S - Sale | $1.12 | -78,633 | 13,508,827 | -1% | -$88,247 | +1 | +1 | -1 | ||
| D | 2017-01-28 | VVUS | Varghese Santosh T | Chief Medical Officer | S - Sale+OE | $1.11 | -429 | 74,037 | -1% | -$476 | +1 | -2 | +1 | ||
2016-12-31 | VVUS | Varghese Santosh T | Chief Medical Officer | S - Sale | $1.12 | -13,790 | 74,466 | -16% | -$15,478 | +3 | 0 | -9 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |